ABSTRACT
Werner syndrome is a segmental progeroid disease characterized by increased cancer and acceleration of specific age-related phenotypes, due to loss of a protein known as WRN. Extensive research over the last decade has revealed much about WRN biochemistry and the etiology of Werner syndrome. WRN possesses multiple DNA-dependent enzymatic activities (ATPase, helicase, exonuclease, and strand annealing) and interacts with factors having established roles in DNA metabolic pathways. Although the exact functions of WRN remain unclear, accumulating evidence points to roles in proper resolution of replication blockage and in telomere maintenance. If WRN function is lost (as exemplified in cells from Werner patients), problems with replication and DNA damage processing arise, probably resulting in an increased number or persistence of strand breaks. In turn, these events lead to chromosomal and telomeric abnormalities or activate checkpoints that bring about early senescence or increased apoptosis. Thus, elevated cancer incidence associated with Werner syndrome is due to increased chromosomal changes, while the accelerated aging characteristics probably stem from telomere dysfunction leading to accumulation of non-functional senescent cells or excessive apoptotic cell death over time. More research is needed to determine whether these specific DNA-dependent mechanisms contribute to development of aging characteristics in normal individuals.
INTRODUCTION
A large body of research has clearly shown that genomic instability plays a key role in tumor initiation and progression.
Human hereditary diseases that show increased genomic instability and elevated cancer incidence have provided valuable insight into the cellular processes that suppress genetic change and therefore, carcinogenesis. In fact, much of our current knowledge about DNA repair and checkpoint pathways in humans stems from research into the molecular bases of these genomic instability syndromes. Even with these protective mechanisms intact, genetic change in cells still occurs over time and thus the probability of cancer increases with age. This raises the critical question of whether genetic change might be involved in the development of aging phenotypes other than cancer. In support of this hypothesis, some cancerprone hereditary diseases also show accelerated development or increased frequency of other characteristics or pathologies normally associated with aging. Of these diseases, Werner syndrome (WS), first identified by Otto Werner in 1904 (1), has gained increased attention recently as an excellent model system for examining the potential relationship between genomic instability and aging.
WS or "adult progeria" is an autosomal recessive segmental progeroid disease, showing accelerated development of some but not all features of normal aging (2, 3) . In contrast to other progeroid syndromes, individuals Figure 1. WRN and other key RecQ family members. The human RecQ family members (hsWRN, hsBLM, hsRecQ4, hsRecQ5β and hsRecQ1) along with spRqh1, scSgs1, and ecRecQ, the lone RecQ homologs from S. pombe, S. cerevisiae, and E. coli, respectively, are aligned with respect to their conserved ATPase/helicase motifs (in red). Other domains of interest are depicted and identified by the guide at bottom. The RecQ-conserved C-terminal homology region or RQC domain (in orange) is bisected (dotted line) into Zn finger and winged helix subdomains as indicated above the WRN protein map.
with WS are asymptomatic in early childhood and often go undiagnosed until beyond twenty years of age. This relatively normal developmental period suggests that WS might be a better model for aging research than other progeroid syndromes that have earlier onset phenotypes arising from severe developmental defects. During their teenage years, individuals with WS fail to undergo the normal adolescent growth spurt resulting in generally short stature. With time, they also begin to show accelerated development or increased frequency of many age-related features including cataracts, atherosclerosis, osteoporosis, hypogonadism, diabetes mellitus type II, hypertension, graying and loss of hair, and wrinkling of the skin. As for most diseases showing increased genomic instability, an elevated incidence of cancer is associated with WS. However, there is a marked increase in tumors derived from tissues of mesenchymal origin (soft tissue sarcomas and osteosarcomas) in WS, perhaps indicating that these cell types are particularly vulnerable to the molecular defect(s) underlying the syndrome. Unlike normal aging, no obvious advancement of neurodegeneration is associated with WS, an outcome possibly related to the early differentiation and post-mitotic status of neural tissue. Individuals with WS generally die before age 50 either from cancer or heart disease. Although WS does not display accelerated development of the total spectrum of normal aging characteristics, the specific phenotypes observed in WS provide a good starting point for examining a potential role for genomic instability in normal aging.
GENETIC BASIS OF WS
Another reason that WS has been touted as an excellent model for aging research is its genetic simplicity. Amazingly, all of the WS phenotypes mentioned above result from defects in both alleles of a single gene, known as WRN, located at chromosome position 8p12 (4, 5) . At its very C-terminus, WRN contains a nuclear localization sequence (Figure 1) .
Intriguingly, all of the WRN mutations identified in individuals with WS truncate the gene product prior to this nuclear localization signal (6, 7) . This has led to speculation that the observed aging phenotypes result from the total absence of WRN function due to the inability of these truncated proteins to enter the nucleus. Consistent with the idea of a null phenotype, the truncated versions of WRN conferred by patient mutations are not generally detectable in cells, probably due to their improper conformation and rapid degradation (8, 9) . Thus, the confluence of premature aging phenotypes in WS patients with markedly different mutations is likely explained by a complete loss of WRN function.
Since a complete absence of WRN function leads to a profound acceleration of specific aging phenotypes, it is tempting to speculate that either altered WRN expression (for example, due to loss of one allele) or various combinations of WRN polymorphisms or missense mutations may influence the time of onset or frequency of specific aging features even in phenotypically normal individuals. Consistent with the former possibility, cells from WRN heterozygotes with one null allele have intermediate phenotypes regarding DNA damage sensitivity (10) . In support of the latter, a specific polymorphism resulting in a Cys to Arg change at amino acid residue 1361 correlates to a higher rate of osteoporosis in a Japanese population while the Arg allele seems to be protective against myocardial infarction (11, 12) . However, this same polymorphism did not either alter WRN function in vitro or result in differences in coronary artery disease in a Caucasian population (13) , suggesting possible effects of genetic background on WRN function.
THE WRN GENE PRODUCT

Primary sequence and structural information
The WRN gene product encodes a protein of 1432 amino acids with an approximate molecular weight of 162 kilodaltons and, based on sequence motifs in its central region, belongs to the RecQ family of helicases (5 (Figure 1) , including the BLM and RECQ4 gene products that are defective in the cancer-prone Bloom and RothmundThomson syndromes, respectively (14, 15) . Furthermore, certain mutations in RECQ4 cause RAPADILINO or Baller-Gerold syndrome, each phenotypically similar to Rothmund-Thomson but apparently with significantly lower cancer risk (16, 17) . Although the human RecQ family members are highly homologous within the sequence motifs that comprise their helicase domains, other regions outside of this domain are mostly dissimilar ( Figure  1 ). However, there are two regions of weak homology (the RQC and HRDC domains) C-terminal to the helicase domain that are shared between WRN and BLM orthologs as well as some other RecQ family members. A recent crystal structure of Escherichia coli RecQ (18) has demonstrated that the RQC domain is divided into two structural entities, a Zn finger and a winged helix domain. Studies with isolated RQC and HRDC domains from WRN and other RecQ members indicate that each domain folds into a distinct structural entity with DNA binding affinity (19) (20) (21) (22) . WRN is the only human RecQ member to have three sequence blocks in its N-terminal region that are typical of nucleases (23), suggesting that loss of not only its helicase but also its exonuclease activity (see below) contributes to the unique WS phenotype. It is notable that WRN orthologs containing both nuclease and helicase domains have been identified in mouse (mWrn) and Xenopus laevis (FFA-1/xlWRN) but not in prokaryotes, lower eukaryotes, or Drosophila melanogaster (24, 25) . However, there are indications that in plants and lower eukaryotes, WRN-like exonuclease and helicase functions may reside in separate genes (26).
Association of WRN with Other DNA Metabolic Factors
WRN has been shown to associate or interact directly with many factors that participate in DNA metabolism or are involved in the cellular response to DNA damage. A list of factors that interact with WRN is presented in Table 1 . A complete description of each of these interactions and their potential relevance to WRN function is beyond the scope of this review. However, efforts have been made in the following sections to refer to specific interactions that may influence either WRN activities in vitro or its potential DNA metabolic roles in vivo.
ATPase and Helicase Activities
As predicted from its strong homology to RecQ helicases and weaker homology to a very large family of ATPase and nucleic acid unwinding enzymes, the central region of WRN confers ATPase activity that provides the energy for unwinding nucleic acids. Not surprisingly, deletions that remove or partially truncate the helicase domain and substitution mutations at conserved residues (K577M and R834C) in the ATPase/helicase motifs disable ATPase and unwinding activities (27, 28) . The ATPase activity of WRN is essentially undetectable unless DNA (or RNA) is present, with single-stranded DNA optimally stimulating this activity (29) . WRN alone unwinds short regions of duplex DNA with a 3' to 5' directionality in a reaction mediated by ATP hydrolysis; dATP, CTP, or dCTP can substitute (at least partially) for ATP in driving WRN-mediated unwinding (30) . The helicase activity of WRN appears especially robust on unusual DNA structures including triplexes, 2-, 3-and 4-stranded fork structures and 3-stranded displacement (D-)loops (31) (32) (33) (34) .
In addition, this activity mediates branch migration of Holliday junctions and disruption of G-quartet structures that might occur in guanine-rich regions including telomeres and ribosomal DNA arrays (31, 35, 36) . It is notable that the DNA substrate specificity for WRN helicase activity is remarkably similar to that of the human BLM protein. WRN alone is relatively weak helicase, being able to unwind duplexes longer than 40 bp only with extreme difficulty; this may partially be due to the recently identified annealing activity (see below) also present in WRN that tends to counteract simple unwinding. However, a direct interaction with replication protein A (RPA), the human single-stranded binding factor, permits WRN to unwind much longer duplexes (up to several hundred bp) in a manner not duplicated by heterologous single-stranded binding proteins (30, 37) . Other interacting proteins (such as p53, RAD52, TRF2, and POT1) have been shown to regulate WRN unwinding activity either positively or negatively (38-41).
Annealing Activity
WRN also facilitates the pairing of complementary DNA strands (42). This appears to be a property shared between multiple RecQ family members, including BLM, RecQ1, RecQ5β, and Drosophila melanogaster RecQ5b (42-45). Although it has been suggested that conserved C-terminal regions (RQC and HRDC) of these proteins are necessary for annealing, the structural basis for this activity remains unclear. WRN pairs complementary single-stranded oligomers (at greater than 250-fold the spontaneous rate at sub-nM DNA concentrations) in a manner that directly opposes unwinding, suggesting that the actual WRN unwinding strength may have been underestimated (42, 46) . WRN also mediates pairing of third strands to complementary singlestranded regions in fork and bubble substrates; on forked structures, coordination between pairing and unwinding promotes strand exchange (42). It seems likely that such coordination between pairing and unwinding activities of WRN may be responsible for its strong branch migration activity (36) and possibly other recombination-related properties.
Exonuclease Activity
The nuclease domain at the N-terminus of WRN confers a 3' to 5' exonuclease activity to the full length protein (47, 48) . Mutations at conserved residues in this domain (D82A and E84A) specifically eliminate this activity (47) . On partial duplex structures, the exonuclease activity of WRN appears most robust on recessed and mismatched 3' ends (49) . WRN preferentially digests 3' ends or nicks within complex structures containing bubbles, D-loops, stem-loops, and Holliday junctions that are also excellent substrates for its helicase function (34, 50, 51) . The isolated N-terminal domain of WRN retains 3' to 5' exonuclease activity (51, 52) and may have endonuclease activity under certain conditions (53) , indicating that it folds into a functional unit that is structurally separate from the remainder of the protein. The exonuclease activity of WRN can be stimulated by its interaction with Ku heterodimer or NDH II (54-56); Ku allows WRN to degrade DNA containing minor base lesions that normally block the exonuclease activity of WRN alone (57, 58) . WRN exonuclease activity is specifically enhanced on telomeric substrates by an interaction with TRF2 (59). In contrast, WRN exonuclease activity is inhibited by p53 or BLM (60,61).
DNA Binding Activity
As might be expected from an enzyme with helicase and exonuclease activity, WRN has DNA binding capability. In the absence of interacting proteins, the binding affinity of WRN appears to be dependent upon DNA structure with no apparent nucleotide sequence preference. WRN binds better to single-stranded than double-stranded DNA, and without preferential affinity to DNA containing oxidative damage, UV-induced photoproducts, or 4-nitroquinoline-1-oxide (4NQO) adducts (29) . Recently, WRN was shown to bind to singlestranded DNA in a manner influenced by substrate length (62) . Electrophoretic mobility shift assays show that WRN binds most stably to unusual DNA structures, with highest affinity for substrates containing bubbles, unpaired loops, stem-loops, and D-loops (34, 50) . Experiments using truncated versions of WRN show that four distinct regions have DNA binding properties, including the isolated helicase, RQC, and HRDC domains; the exonuclease domain also binds DNA, but more weakly (20, 62) . Thus, varying levels of exonuclease and helicase activities on different DNA structures likely stem from binding preferences conferred by the helicase domain and Cterminal regions of WRN. This is also consistent with structural information obtained on specific domains of WRN and other RecQ family members (18, 19, 21, 63, 64) . In general, the existing evidence suggests that the 3-dimensional conformation of WRN is organized to bind multiple sites on 3-or 4-stranded DNA structures, most likely replication or recombination intermediates.
Modification and Subcellular Localization of WRN
As for countless other proteins, the cellular function of WRN appears to be regulated by posttranslational modifications.
Although some WRN phosphorylation may be detected in undamaged cells, DNA replication inhibitors and certain DNA damaging treatments trigger acetylation and increased phosphorylation of WRN (65) (66) (67) (68) (69) . The acetylation and phosphorylation status of WRN appears to regulate its trafficking between subnuclear compartments (see below).
In addition, phosphorylation of WRN has been shown to modulate its exonuclease and helicase functions (65, 67) . WRN phosphorylation after replication arrest is mediated by primarily an ATR-dependent pathway, while phosphorylation in response to DNA damage may be mediated (possibly in a redundant manner) by ATR-, ATM-or DNA-PK-dependent pathways (67, 68) . These phosphotidylinositol-3-kinase family members phosphorylate serine and threonine residues specifically at SQ and TQ sequences in their target proteins (70) . WRN contains eight such sequences, six of which are located C-terminal to the conserved helicase domain. Notably, a synthetic peptide derived from WRN including serine 1141 was shown to be preferentially phosphorylated by ATM, ATR, and DNA-PK (71). In addition, tyrosine phosphorylation of WRN has been observed following treatment with mitomycin C, but the responsible kinase(s) are unknown (69) . Ectopically expressed WRN is modified by ubiquitin-like SUMO-1 molecules within cells (72) , although the putative function of this modification remains unclear.
Immunofluorescence studies indicate that WRN is localized within the nucleus, consistent with its putative roles in DNA metabolism. However, its subnuclear distribution varies depending upon cellular circumstances. In unperturbed proliferating cells, WRN is diffusely distributed throughout the nucleus with, in some circumstances, a more intense association with the nucleolus that may be regulated by its phosphorylation status (9, 69, 73) . In a subset of proliferating cells, discrete nuclear foci containing WRN are sometimes observed; such foci are found in cells in S phase and correspond to DNA replication "factories" (74, 75) . In quiescent cells, WRN may become dissociated from the nucleolus (73) .
Curiously, mouse WRN shows only nucleoplasmic (and not nucleolar) localization, perhaps due to its lack of a nucleolar targeting sequence that is present in human WRN (9, 76) .
Treatment of cells with certain DNA damaging agents or replication inhibitors also alters the subnuclear localization of WRN. WRN relocalization can be triggered by treatment of cells with ionizing radiation, bleomycin, hydrogen peroxide, 4NQO, mitomycin C, methylmethane sulfonate, camptothecin, etoposide, hydroxyurea (HU), and UV irradiation (to a much smaller degree) (58, 69, 73, 77) . In these instances, a significant amount of WRN migrates into discrete nuclear foci that correspond to sites of ongoing or arrested DNA replication (74, 75, 77) . Other DNA metabolic factors found in these foci include PCNA, RPA, RAD51, RAD52, ATR, the MRN complex and Ku (36, 40, 58, 68, 74, (77) (78) (79) . This redistribution to discrete foci following DNA damage appears to correlate with lysine acetylation of WRN (66, 69) and is reversible, with WRN returning to its predominant nucleolar localization after varying intervals depending upon the agent used (69).
WS CELLULAR PHENOTYPES AND POTENTIAL ROLES FOR WRN IN DNA METABOLISM
Genomic Instability and DNA Damage Hypersensitivity
Cells from WS patients have an elevated frequency of spontaneous chromosomal aberrations characterized by deletions, insertions, and translocations (80-82), a phenotype undoubtedly responsible for at least the increased cancer disposition associated with the disease. These types of mutations are probably due to misrejoining of unrelated double-strand breaks by non-homologous end joining (NHEJ) pathways.
This particular genomic instability phenotype probably results from an increased number or longer persistence of DNA strand breaks. Consistent with this notion, the numbers of DNA breaks that occur spontaneously or persist following treatment with specific DNA damaging agents (4NQO, topoisomerase II inhibitor VP16, and topoisomerase I inhibitor camptothecin) are higher in WS cells than in normal cells (81, 83, 84) .
Since cells from certain hereditary syndromes with genomic instability and increased cancer frequency were found to have defined defects in DNA damage processing, WS cells have also been extensively investigated for cell survival following various DNA damaging treatments. Among the many agents tested, cells with WRN deficiencies are hypersensitive to the effects of 4NQO, camptothecin, interstrand crosslinking agents including mitomycin C, cisplatin, and mephalan, and MeLex, an alkylating agent that predominantly generates 3-methyladenine lesions (10, 24, (84) (85) (86) (87) (88) . Intriguingly, survival following cisplatin treatment appears to be normal if WRN proteins having only helicase or only exonuclease activity are expressed (89) . Although various reports are somewhat contradictory, there may also be a modest sensitivity of WS cells to ionizing radiation (65) . There is no apparent hypersensitivity of WS cells to UV irradiation (90), the agent of choice when examining potential deficiencies in nucleotide excision repair (NER). In assessing these findings, it must be kept in mind that hypersensitivity as measured by cell survival can involve much more than just the efficiency of DNA adduct removal. In fact, the structurally diverse lesions generated by these agents are subject to direct removal by disparate repair pathways (NER, base excision repair, double-strand break repair), suggesting that WRN is not essential for any one of these specific repair pathways. Instead, these results support the idea that WRN is involved in an alternate (backup) pathway that either removes lesions or allows the cell to replicate and survive in the presence of damage, perhaps a mechanism that takes effect when persistent lesions with dissimilar structural properties block the progression of replication forks.
In this regard, the established hypersensitivity of WS cells to HU is particularly illustrative (84, 91) , since HU inhibits replication fork progression by depleting nucleotide pools and not by generating polymerase-blocking adducts. Notably, the observed hypersensitivities of WS cells following DNA damaging or replication blocking treatments appear to result specifically from apoptotic cell death of S or G 2 phase cells (84).
DNA Replication, Repair, and Recombination Abnormalities
Even in the absence of exogenous DNA damage, cells derived from WS patients have longer cell division cycles than their normal counterparts. This longer division cycle is apparently due to a specific extension of S phase and a slower overall rate of DNA replication (90, 92, 93) . Examination of DNA replication properties in WS cells has revealed an increase in replicon size (94) and asymmetry in the progression of bidirectional replication forks (74) . Consistent with a possible role in DNA replication, WRN has been isolated as part of a DNA replication complex and has been shown to interact with a number of factors directly involved in DNA replication including DNA polymerase δ, PCNA, RPA, and FEN-1 (37, 75, (95) (96) (97) . Furthermore, WRN can be found associated with nuclear foci that correspond to sites of deoxynucleotide incorporation (74, 75) . Although not required for DNA replication in nuclei from reconstituted Xenopus egg extracts, the WRN ortholog FFA-1 also is involved in formation of discrete replication foci (25, 98) . WRN expression is upregulated during S and G 2 phases in highly proliferative, transformed cell lines, suggesting that its function may be tied to DNA replication (99) . Taken together, this data suggests that WRN may play a non-essential but important role in optimizing DNA replication.
The nature of genomic instability observed in WRN-deficient cells suggests improper processing of DNA breaks that are normally repaired by NHEJ or homologous recombination (HR). In line with this notion, deletions at the rejoining point in plasmid-based assays are much more extensive in WS cells than normal cells even though rejoining efficiency is not compromised (100, 101) . A role for WRN in processing of DNA breaks may be facilitated by its physical and functional interactions with two factors, PARP1 and the Ku heterodimer, that bind directly to DNA breaks, the latter either alone or in conjunction with the DNA-dependent protein kinase (DNA-PK) complex that contains Ku and the DNA-PK catalytic subunit (54, 55, 58, 65, 67, (102) (103) (104) (105) .
There is also considerable evidence for the participation of WRN in recombinational repair, including a large body of research on RecQ, Sgs1 and Rqh1, the lone RecQ family members in Escherichia coli, Saccharomyces cerevisiae and Schizosaccharomyces pombe, respectively (reviewed in [106] [107] [108] [109] . Direct examination of WRN-deficient cells revealed a defective mitotic recombination phenotype (110) . A more in-depth molecular and genetic analysis suggested that WRN might be involved in Holliday junction resolution during HR, as introduction of a heterologous resolvase complemented an intrachromosomal recombination deficiency associated with WS cells (91) . It is of note that both the helicase and exonuclease activities of WRN are required to achieve normal levels of recombination using this intrachromosomal recombination assay (89) . In addition to the aforementioned hypersensitivity of WS cells to DNA crosslinking agents, recent molecular studies (111) suggest a functional role for WRN in interstrand crosslink repair pathways that may also have a recombinational component. Research with the Xenopus system suggests that WRN might participate in single-strand annealing, a pathway that may be important for repairing DNA breaks specifically within repetitive regions of DNA (112) . Although the genomic instability phenotype of WS cells implies a problem in suppressing the aberrant rejoining of doublestrand breaks, an essential role for WRN in strand break repair seems unlikely, due to the relative insensitivity of WS cells (compared to cells deficient in HR factors, PARP1 or subunits of DNA-PK complex) to agents that induce these highly deleterious lesions in DNA.
The sometimes discordant observations from WRN-deficient cells might be explained by a defective response to blockage of replication fork movement. Replication blockage may be a relatively common event, caused by persistent endogenous or exogenous damage or secondary structures in the DNA template. It has been recognized within the last decade that the completion of replication often necessitates recombinational functions, ostensibly to deal with blocked replication forks and restart replication (113) (114) (115) (116) (117) . As for some other RecQ-deficient conditions, the phenotypes of WS cells are consistent with a possible role for WRN in pathways that help overcome replication blockage and restart replication to both allow cell survival and minimize genomic instability. In the absence of WRN function, replication blockage may lead to increased DNA strand breaks that are rejoined in errorprone manners, possibly explaining the genomic instability phenotypes of WS cells. Moreover, the lowered survival of WS cells following certain DNA damaging treatments may be due to the inability to overcome replication blocking events leading to S and G 2 checkpoint activation and eventually resulting in apoptotic cell death.
Premature Cellular Senescence
Cellular or replicative senescence due to permanent exit from the cell cycle was first recognized for primary fibroblasts in culture by Hayflick (118) and has since been touted as a potential mechanism in the development of aging characteristics (119) (120) (121) . This connection between cellular senescence and aging has received considerable support due to the abnormal growth kinetics of cells derived from individuals with WS. WS primary skin fibroblasts undergo premature cellular senescence after only about 15-25 population doublings (PDLs), compared to, on average, 50-80 PDLs for normal primary fibroblasts (122, 123) . Although senescence can be reached via different molecular pathways, a prominent route is through shortening and deprotection of telomeres, the highly repeated sequences at chromosome ends. The senescence of WS fibroblasts is quite similar to that of normal fibroblasts undergoing telomere-mediated senescence, except that WS cells apparently retain c-Fos inducibility (124, 125) .
Introduction of the telomere maintenance enzyme telomerase prevents the replicative senescence of WS primary fibroblasts (126) (127) (128) . This result has been interpreted in two different ways: 1) telomerase promotes takeover of cultures by clonal division of remaining cells that have not activated a senescence checkpoint (129) or 2) WS cells have a telomere maintenance defect (see below) that is rescued by telomerase expression.
Abnormal Telomere Dynamics
There is accumulating evidence that WRN has a specific function in telomere maintenance, and that loss of this function is responsible for the premature onset of the specific aging phenotypes presented in WS. Most somatic cells (including primary fibroblasts) do not express detectable levels of the telomere lengthening enzyme telomerase, and thus the telomeric ends of their chromosomes may be depleted over time by either gradual shortening due to the end replication problem or stochastic deletions. Changes in telomeric structure resulting from critically shortened and/or unprotected telomeres expose the chromosome ends as DNA double-strand breaks, triggering ATM-and p53-dependent checkpoint pathways and subsequently either senescence or apoptosis (130, 131) . Thus, it has been suggested that telomere shortening serves as a clock to limit the number of divisions that cells can undergo, a mechanism that is widely believed to suppress tumorigenesis. After this connection between telomere dysfunction and at least certain instances of cellular senescence was established (132) , investigations of telomere dynamics in cells lacking WRN function began in earnest. Studies of telomeric restriction fragment length in genomic DNA isolated from WS primary fibroblasts showed a faster rate of telomere erosion than normal fibroblasts, but WS cells senesced with somewhat longer telomeres, on average, than normal cells (133) . When similar assays were performed in immortalized cells, normal cells showed typical telomere erosion profiles, while WS cells showed telomere lengths that fluctuated dramatically over time (134) . Importantly, introduction of telomerase into WS fibroblasts essentially resulted in their immortalization (126) (127) (128) , providing a direct link between possible telomere dysfunction in these cells and their premature senescence phenotype.
This link has been further strengthened by recent studies on mice lacking both telomerase and mWrn. Generation of mWrn-deficient mice was somewhat disappointing in that no overt premature aging or cancerprone phenotypes were observed (24, 135, 136) . However, strains generally used for generation of transgenic and knockout mice have very long (20-50 kb) telomeres, and even a complete deficiency of telomerase activity causes no overt phenotype until six or more generations (137) . In this light, mWrn function was hypothesized to be less important or even dispensable in mice with very long telomeres and intact telomerase. To examine whether mWrn function might be important when telomere length was limited, telomerase-deficient mice were crossed with mWrndeficient mice. When late generation (generation 3-5) telomerase-deficient mice containing shortened telomeres were used, an additional mWrn-deficiency resulted in replicative senescence at the cellular level and appearance of premature aging phenotypes (cataracts, osteoporosis, alopecia, and elevated mesenchymal tumors) reminiscent of human WS (138, 139) . When cells taken from these doubly-deficient mice were passaged in culture, survivors that escape from senescence arose at an elevated frequency, and these survivors showed evidence of telomeric recombination including an upregulation of the alternative lengthening of telomeres (ALT) pathway (140) . This suggests that mWrn might act in a pathway that directly or indirectly suppresses telomeric recombination.
Other evidence also supports a specific function for WRN in telomere metabolism. WRN co-localizes with the telomeric repeat binding factors TRF1 and TRF2 (141, 142) and telomeric DNA in late S phase (142, 143) and co-immunoprecipitates with TRF2 (39) . Expression of a dominant-negative, helicase-deficient WRN mutant protein in normal cells results in stochastic loss of telomeric sequences and chromosome fusions (143, 144) . One of these reports (143) suggests that these telomeric deletions result from a problem in replication of the lagging (G-rich) strand of telomeres. Biochemical studies demonstrate a direct physical and functional interaction between WRN and TRF2 (59, 142) . This interaction serves to enhance the helicase and exonuclease activities of WRN particularly on DNA substrates with telomeric character. These data are consistent with a model by which TRF2 recruits WRN to its site of action on telomeric structures (59) . Recently, a functional interaction was observed between WRN and POT1, another telomeric protein that specifically binds to the single-stranded (G-strand) overhang at the telomeric ends (41).
Although additional roles are possible, this evidence strongly suggests that WRN functions in telomere maintenance. Hypothetically, telomere dysfunction occurs earlier and more often when WRN is absent, triggering activation of checkpoint pathways that result in senescence or apoptosis at an increased frequency during cellular life span. Transfection of WRN-deficient cells with telomerase rescues this defect, presumably by adding telomeric sequences de novo to depleted telomeric ends and preventing the activation of checkpoint pathways. What role might WRN play at telomeres? It seems likely that, at the molecular level, loss of WRN results in perhaps occasional telomeric deletions that can shorten individual telomeric ends by varying degrees. This phenotype may be due to 1) loss of direct effect of WRN in suppressing intra-or intertelomeric recombination events, 2) loss of the ability to properly resolve telomeric recombination events, or 3) loss of an effect of WRN during replication of telomeric regions such as disruption of telomeric secondary structures (G-quartets or telomeric loops) that directly truncates telomeric regions or indirectly increases the frequency or necessity of telomeric recombination. With regard to the third mechanism, it is notable that recombination pathways are thought to be essential to overcoming or circumventing replication blocks and reforming a functional replication fork.
PERSPECTIVE
Similar to the genomic instability phenotypes of other RecQ-deficiencies, the WS cellular phenotypes suggest that WRN function is important for minimizing large-scale chromosomal aberrations. However, WS is certainly phenotypically unique, with a much higher prevalence of premature aging phenotypes but a lower cancer frequency when compared with Bloom syndrome. This would suggest that the DNA metabolic functions of WRN are distinct from or at least only partially redundant with other human RecQ helicases, even though the WRN and BLM proteins have many enzymatic similarities. At this time, the preponderance of evidence points to functions for WRN in proper resolution of telomere maintenance, replication blockage, and perhaps other pathways responding to DNA damage. It is certainly possible that these functions are independent, and loss of WRN function would cause overall genomic instability and telomerespecific abnormalities. Alternatively, WRN may play a single role in DNA metabolism that, when lost, has an acute effect in telomeric regions due to their highly repetitive nature. It seems possible that, within repetitive regions of DNA, recombinational repair pathways may be particularly subject to alignment or resolution problems that may lead to increased insertion or deletion events. By this reasoning, both the overall genome instability and the telomere-related changes might be due to a single defect that leads to increased recombination or the improper resolution of a specific recombinational repair pathway. These and other specific questions regarding the functions of WRN in DNA metabolism are yet to be elucidated.
It seems clear that genomic instability caused by WRN deficiency is responsible for the increased cancer incidence in WS (Figure 2 ). However, it remains to be determined why mesenchymal tumor types such as soft tissue sarcomas and osteosarcomas are disproportionately associated with loss of WRN function. In regard to this issue, it may be noteworthy that soft tissue sarcomas and osteosarcomas often use the ALT pathway to maintain telomere length instead of reactivating telomerase (145) . This suggests that mechanisms related to telomere maintenance that are specifically operable in cells of mesenchymal origin could impact tumor initiation and progression. In one scenario, ALT pathways may be highly active in cells of mesenchymal origin. If, as mentioned above, WRN functions to suppress or properly resolve telomeric recombination events, a WRN deficiency may lead to higher rates of genomic instability due to aberrant telomeric recombination or more frequent telomere deprotection in mesenchymal cell types that result in higher relative appearance of mesenchymal tumors.
In an alternative scenario, telomerase may be more highly repressed in mesenchymal cells than in other cell types. Although this might tend to suppress tumorigenesis overall, perhaps this also results more often in use of ALT to maintain telomeres and, when combined with a loss of WRN function, a similar sequence of events as outlined for the former mechanism.
The study of WS has already provided and will continue to produce mechanistic insights into the relationship between genomic instability and the accelerated development of age-related phenotypes associated with the syndrome. These same mechanisms may also contribute, albeit later, to development of aging characteristics in normal individuals. The acceleration of aging phenotypes other than cancer in WS can be most likely explained by DNA metabolic problems that activate checkpoints resulting in apoptosis or senescence (Figure 2 ). Over time, apoptotic cell death or gradual accumulation of non-functional senescent cells could either directly diminish tissue function or drain the pool of replicating cells and thus weaken the proliferative and regenerative capacity of certain tissues, particularly those that require sustained proliferation over lifetime for proper function. Although apoptosis is clearly protective against tumorigenesis, it is widely believed to play a key role in the development of many aging characteristics. However, apoptosis may be initiated by DNA-independent mechanisms as well as by DNA-mediated events. Although senescence and apoptosis due to telomeric dysfunction or genome-wide DNA metabolic problems apparently result in accelerated development of specific aging characteristics in WS, it is unclear whether DNAmediated apoptosis and senescence play roles in normal aging. Further research is needed to determine whether and to what extent genomic instability and telomere-related mechanisms contribute to specific aging phenotypes in normal individuals.
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